Skip to content

Prevention of Postoperative Acute Kidney Injury

Effect of a Kidney Bundle on the Occurence of Postoperative Acute Kidney Injury in Patients at Risk

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02583945
Acronym
PrevenAKI
Enrollment
0
Registered
2015-10-22
Start date
2015-10-31
Completion date
2017-10-31
Last updated
2018-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Keywords

acute kidney injury, hemodynamic stabilisation, nephrotoxic medication

Brief summary

Postoperative acute kidney injury (AKI) refers to increased mortality and morbidity in patients after non-cardiac surgery. The Kidney Disease Improving Global Outcomes (KDIGO)-guidelines recommend a bundle of procedures to prevent the occurrence of AKI: A protocol for the improvement of the hemodynamic situation and a standardized proceeding in hemodynamic monitoring, consequent avoidance of nephrotoxic substances, regular measurement of creatinine and urine output, as well as normoglycemia. The primary goal is to determine if the consequent application of the KDIGO-bundle leads to a prevention of the occurrence of AKI in patients at risk after non-cardiac surgery.

Detailed description

All patients included in the study will be treated with the KDIGO-bundle (hemodynamic stabilization, avoidance of nephrotoxic substances, normoglycemia and measurement of creatinine in serum and urine output). 12 h, 24h as well as on day 2, 3, 5 and 10 after admission on ICU the occurence of AKI (according to KDIGO) will be assessed.

Interventions

PROCEDUREkidney treatment bundle (KDIGO)

Application of the measures of the kidney treatment bundle.

Sponsors

Wuerzburg University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 65 years * chronic kidney disease * diabetes mellitus, chronic heart, lung or liver disease * hemodynamic instability (intra and/or post-operative) * trauma, burn injury, major surgery, usage of x-ray contrast and sepsis.

Exclusion criteria

* Age \< 18 years * pregnancy * kidney graft recipient * chronic renal disease with or without renal replacement therapy and cardiac surgery.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of postoperative AKIuntil day 5 after surgeryAKI according to KDIGO definition

Secondary

MeasureTime frame
hospital mortalityup to 100 days after surgery
usage of renal replacement therapy (hours)up to 30 days after surgery
length of invasive respirator therapy (hours)up to 30 days after surgery
Intensive care unit mortality28 days and 90 days after surgery
urine output (total ml)after 12 hours, on day 2 (in 24hour), 3 (in 24hour), 5 (in 24hour) and 10 (in 24hour) after surgery
length of hospital stayup to 100 days after surgery
length of ICU stayup to 100 days after surgery
creatinine in serum12 hours, day 2, 3, 5 and 10 after surgery

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026